Brind.

CRISPR Therapeutics is discussing commercial priorities and expanding treatment access into new markets with an investment bank.

1 report, 1 independent Updated Sep 14

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

CRISPR Therapeutics Morgan Stanley Western Europe

How it developed

Newest first. Tap a step to see who reported it.

Sep 17CRISPR Therapeutics and Scribe Therapeutics presented at a Morgan Stanley conference, highlighting their competition in gene-editing therapeutics.Sub-event
Sep 14CRISPR Therapeutics discusses commercial priorities and market expansion with Morgan Stanley.1 source
- tickerreport.com

Keep exploring

The entities involved

CRISPR Therapeutics
company in Basel, Switzerland

Nothing else this week.
Morgan Stanley
U.S. investment bank
- Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
- Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
Western Europe
western part of the European continent
- A heat dome is affecting Spain, Italy, and the UK, prompting weather warnings across Europe.Mon 17:01
- W.P. Carey holds a large portfolio in the United States and Western Europe, with top 10 tenants accounting for 19.4% of ABR.Sun 05:51

Related events

Coverage

Newest first; wire copies grouped

Sep 14tickerreport.com